Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-25

Clinical Trial Update: A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating lacosamide as add-on therapy for children with epilepsy characterized by partial-onset seizures has completed, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 3 | Status: COMPLETED | Results posted: 2022-10-25